208 related articles for article (PubMed ID: 21439516)
81. Inflammatory markers as risk factors for infection with multidrug-resistant microbes in diabetic foot subjects.
Noor S; Borse AG; Ozair M; Raghav A; Parwez I; Ahmad J
Foot (Edinb); 2017 Aug; 32():44-48. PubMed ID: 28802182
[TBL] [Abstract][Full Text] [Related]
82. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria.
Zinner SH
Clin Infect Dis; 1999 Sep; 29(3):490-4. PubMed ID: 10530434
[TBL] [Abstract][Full Text] [Related]
83. Antimicrobial resistance--pharmacological solutions.
Rubinstein E
Infection; 1999; 27 Suppl 2():S32-4. PubMed ID: 10885825
[TBL] [Abstract][Full Text] [Related]
84. Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis.
Ramos JM; Vidal I; Bellot P; Gómez-Hurtado I; Zapater P; Such J
Gut; 2016 Jan; 65(1):182-3. PubMed ID: 25832107
[No Abstract] [Full Text] [Related]
85. PROTEKT years 1-3 (1999-2002): study design and methodology.
Harding I; Felmingham D
J Chemother; 2004 Dec; 16 Suppl 6():9-18. PubMed ID: 15690682
[No Abstract] [Full Text] [Related]
86. [Antibiotics of the phosphonic acid group].
Poliak MS
Antibiot Med Biotekhnol; 1987 Jan; 32(1):66-75. PubMed ID: 3551820
[No Abstract] [Full Text] [Related]
87. Examining the relationship between multidrug-resistant organism acquisition and exposure to antimicrobials in long-term care populations: a review.
Shaffer ML; D'Agata EM; Habtemariam D; Mitchell SL
Ann Epidemiol; 2016 Nov; 26(11):810-815. PubMed ID: 27751631
[TBL] [Abstract][Full Text] [Related]
88. Accelerating resistance, inadequate antibacterial drug pipelines and international responses.
Theuretzbacher U
Int J Antimicrob Agents; 2012 Apr; 39(4):295-9. PubMed ID: 22341298
[TBL] [Abstract][Full Text] [Related]
89. [Methods of nucleic acid hybridization: their use in the detection and study of the prevalence of drug resistance genes].
Vakulenko SB
Antibiot Khimioter; 1992 Mar; 37(3):44-50. PubMed ID: 1514868
[No Abstract] [Full Text] [Related]
90. Comparative in-vitro activities of topical antibiotics against conjunctival isolates.
Iqbal J; Rahman M; Kabir MS; Sharif AJ
J Antimicrob Chemother; 1999 Apr; 43(4):611-2. PubMed ID: 10350400
[No Abstract] [Full Text] [Related]
91. [Effect of bile on bacterial sensitivity to antibiotics].
Veselov AIa
Antibiot Med Biotekhnol; 1985 Mar; 30(3):232-3. PubMed ID: 4015064
[No Abstract] [Full Text] [Related]
92. Exploring N-acylhydrazone derivatives against clinical resistant bacterial strains.
Lannes AC; Leal B; Novais JS; Lione V; Monteiro GC; Lourenço AL; Sathler PC; Jordão AK; Rodrigues CR; Cabral LM; Cunha AC; Campos V; Ferreira VF; de Souza MC; Santos DO; Castro HC
Curr Microbiol; 2014 Sep; 69(3):357-64. PubMed ID: 24807624
[TBL] [Abstract][Full Text] [Related]
93. In vitro evaluation of cefpirome: an Australasian study of isolates from intensive care unit and hematology/oncology patients. The Cefpirome Study Group.
Fernandes C; Pritchard R; Morris A; Benn R
Diagn Microbiol Infect Dis; 1998 Jul; 31(3):493-5. PubMed ID: 9635244
[No Abstract] [Full Text] [Related]
94. Multidrug-Resistant Pathogens in Hospitalized Syrian Children.
Kassem DF; Hoffmann Y; Shahar N; Ocampo S; Salomon L; Zonis Z; Glikman D
Emerg Infect Dis; 2017 Jan; 23(1):166-168. PubMed ID: 27618479
[TBL] [Abstract][Full Text] [Related]
95. Antimicrobial peptides: a potential role in ocular therapy.
Aliwarga Y; Hume EB; Lan J; Willcox MD
Clin Exp Ophthalmol; 2001 Jun; 29(3):157-60. PubMed ID: 11446458
[TBL] [Abstract][Full Text] [Related]
96. [The structure of microflora in ulcerative-necrotic lesions in patients with diabetic foot syndrome].
Beliaeva OA; Kryzhevskiĭ VV; Rybianets IuV; Korzhik NP; Ulanovich LI; Shevchenko AV; Bezuglaia EV
Klin Khir; 2010 Oct; (10):20-3. PubMed ID: 21290878
[TBL] [Abstract][Full Text] [Related]
97. Dangerous passengers: multidrug-resistant bacteria on hands and mobile phones.
Martina PF; Martinez M; Centeno CK; VON Specht M; Ferreras J
J Prev Med Hyg; 2019 Dec; 60(4):E293-E299. PubMed ID: 31967086
[TBL] [Abstract][Full Text] [Related]
98. Antimicrobial susceptibility associated with bloodstream infections in children: a referral hospital-based study.
Haghi Ashtiani MT; Mamishi S; Masoomi A; Nasiri N; Hosseini M; Nikmanesh B; Pourakbari B; Rezaei N
Braz J Infect Dis; 2013; 17(4):497-9. PubMed ID: 23809684
[No Abstract] [Full Text] [Related]
99. Combination therapy as a tool to prevent emergence of bacterial resistance.
Mouton JW
Infection; 1999; 27 Suppl 2():S24-8. PubMed ID: 10885823
[TBL] [Abstract][Full Text] [Related]
100. [Analysis of pyogenic microflora structure of a cardiac surgery hospital].
Maslov IuN; Fel'dblium IV; Pegushina OG; Sukhanov SG
Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):80-5. PubMed ID: 22308736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
